Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2 Phase 3 Programs w/ 1 in partnering stage !!
https://www.sec.gov/Archives/edgar/data/1601936/000121390019020863/ex99-1_005.jpg
News out breakout watch
buy and hold. Long and strong. Something is cooking. More News soon? Buyout maybe?
* * $EARS Video Chart 12-30-2019 * *
Link to Video - click here to watch the technical chart video
breakout imminent
News: $EARS Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has obtained...
Read the whole news EARS - Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
Someone willing to drop over $200k on $EARS knows something we don’t.
F off spammer.
* * $EARS Video Chart 06-05-2019 * *
Link to Video - click here to watch the technical chart video
Lost my shares to the R/S.
The F'ed up once.
I do not trust management.
20=1 reverse split today.
What’s with the bid/ask this morning? Either RS going into effect or some ppl about to have an epic day.
RUT ROH!! . . https://ir.aurismedical.com/news-releases/news-release-details/auris-medical-receives-positive-nasdaq-listing-determination[color=blue][/color]
The following table illustrates this dilution to new investors.
Exercise price per common share $ 0.397
Net tangible book value per common share as of December 31, 2018 $ 0.003
Increase in net tangible book value per common share attributable to new investors $ 0.048
As adjusted net tangible book value per common share after the exercise $ 0.051
Dilution per common share to new investors $ 0.346
Percentage of dilution in net tangible book value per common share 87%
News: $EARS Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019
Zug, Switzerland, March 07, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it will provide a business update an...
Find out more https://marketwirenews.com/news-releases/auris-medical-to-report-fourth-quarter-and-full-year-2018-financial-results-and-provide-business-update-on-thursday-march-14-2019-7817426.html
* * $EARS Video Chart 02-13-2019 * *
Link to Video - click here to watch the technical chart video
auris multi billion partnership with Johnson&johnson ??
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
* * $EARS Video Chart 02-11-2019 * *
Link to Video - click here to watch the technical chart video
50 +25% What does that mean?
* * $EARS Video Chart 01-23-2019 * *
Link to Video - click here to watch the technical chart video
EARS .60 +50%
?$EARS Buy as much as you can.?
?Good things (Partnership, Phase 3, FDA, Shareholder Meeting, etc.) coming soon...?
* * $EARS Video Chart 12-24-18 * *
Link to Video - click here to watch the technical chart video
* * $EARS Video Chart 11-29-18 * *
Link to Video - click here to watch the technical chart video
For publicly traded companies it can be a status symbol to have their equity shares listed on a major stock exchange, such as the New York Stock Exchange Euronext or Nasdaq. Listed companies have met a variety of criteria, including financial criteria, established by an exchange, but there is no guarantee the exchange will continue to serve as a stock's trading platform. A stock can become delisted from a major exchange for failing to maintain exchange standards; that does not mean the company is delisted from the entire stock market. Shares may continue to trade in the over-the-counter bulletin board (OTC:BB) market where there are no listing standards.
Stock Price
If a company's stock falls below $1 per share for longer than 30 days, that stock is in danger of losing its listing on the NYSE Euronext or Nasdaq exchange. Fortunately for companies, once a stock falls into the danger price zone, there is still time for the stock price to recover. A letter of notification is sent to company officials, who have another six months for the stock to strengthen to above $1 before shares are delisted from either major U.S. exchange.
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its product candidates include AM-101, which is in phase III clinical development for the treatment of acute inner ear tinnitus; and AM-111 that is in phase III clinical development for the treatment of acute inner ear hearing loss.
* * $EARS Video Chart 11-23-18 * *
Link to Video - click here to watch the technical chart video
* * $EARS Video Chart 11-20-18 * *
Link to Video - click here to watch the technical chart video
Very risky not to cover any short positions right before quarterly statement. I'm shocked this isn't will above a dollar with how much that was shorted.
I would think there would be much more upward action with an update around the corner and being oversold.
With two products in the 3rd phase I'm thinking way over sold. I'm gonna keep gobbling up. Getting ready for thanks giving! GO EARS
That's why I've been buying the dips
Not many posting here. Is the enthusiasm dead here? This can easily bounce back up for a 50 to 300% gain.
Just woke up! Next thurs earnings due and PR to follow. I'm locked and loading. Go EARS
* * $EARS Video Chart 11-05-18 * *
Link to Video - click here to watch the technical chart video
* * $EARS Video Chart 11-02-18 * *
Link to Video - click here to watch the technical chart video
Followers
|
41
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
675
|
Created
|
01/12/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |